Skin disease study to improve treatment choices
Part of Blood & lymphatic, Cancer, Genetic & congenital, Heart & circulation, Immune system & allergy, Infections, Skin clinical trials.
This study looks at different skin diseases to find markers that can help guide treatment. It tests new treatments for several conditions like eczema, psoriasis, and lupus, with the goal of personalizing care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and not pregnant.
- You have one of these skin conditions: atopic dermatitis, cutaneous lupus, chronic hives, hidradenitis suppurativa, mycosis fungoides, or psoriasis.
- You are willing to start a new treatment for your skin condition as part of the study.
- You can avoid washing the study skin area for 12 hours before each visit.
- You agree to not get pregnant during the study (if female).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the health records of people with skin diseases to learn more about their care and outcomes. It may help improve future treatments.
This study aims to better understand inducible urticaria (hives triggered by cold, pressure, or friction) and chronic spontaneous urticaria. Researchers will use skin tests to measure how different triggers affect your skin in detail.
This study follows patients with common chronic skin conditions to see how they change over time. It does not test a new treatment, but collects data from regular doctor visits.
This study looks for clues in your skin and blood that could predict how well you'll respond to treatments for conditions like eczema, psoriasis, or lupus. It aims to help doctors choose the best therapy for you.
This study looks at what affects the “path” (trajectory) of long-lasting inflammatory skin conditions. It may help researchers understand why symptoms change and how treatments or factors influence those changes.
This study looks at the skin’s germs (“microbiome”) in people with atopic dermatitis (eczema) or psoriasis. It may help researchers better understand what’s going on on the skin and how that might relate to disease severity.
Hear when a new Psoriasis (PsO) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.